NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Clock.bio

Clock.bio

Private
CambridgeHealthcare & Life Scienceshttps://clock.bio

Last Round

Seed

Oct 9, 2024

Total Funding Raised

$9.3M

Company Overview

Clock.bio is a biotechnology company that develops regenerative therapies to address age-related diseases by decoding the genetic programs of cellular rejuvenation.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

cellular rejuvenationlongevity biotechCRISPR screeningfunctional genomicsdrug discoverytarget identificationcomputational biologyiPSC researchage-related diseasesingle-cell analysisregenerative medicinebiological datasetanti-aging techlongevity sciencerejuvenation factors

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Clock.bio Comparables

Compare Clock.bio with similar companies based on industry and business-model similarity.

Clock.bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Shift Bioscience
90%
Retro Biosciences
76%
Turn Biotechnologies
75%

Clock.bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 9, 2024
Pre SeedAug 31, 2023

Key People

Founding team and executive leadership

Markus Gstöttner

Chief Executive Officer

Executive Team

Rodrigo Santos

Chief Technology Officer

Executive Team

Clock.bio Investors

Notable investors and investment history

Clock.bio investors
InvestorRounds
LocalGlobeSeed
BlueYard CapitalSeed, Pre Seed
Onsight VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 27, 2025

    Dr. Michael Boehler, formerly of BioNTech, joins as CBO.

Clock.bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Clock.bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Clock.bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Employee Range10
Year Founded2020
Last FundingOct 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.